Literature DB >> 121884

The orally administered anti-allergic agent, sodium nivimedone (BRL 10833); efficacy in bronchial asthma and effects on IgE, complement and eosinophils.

E M Lumb, G J McHardy, A B Kay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 121884      PMCID： PMC1429720          DOI： 10.1111/j.1365-2125.1979.tb05911.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Diurnal variation of asthma.

Authors:  T J Clark; M R Hetzel
Journal:  Br J Dis Chest       Date:  1977-04

2.  Response of asthmatics on three weeks Intal treatment.

Authors:  M Scherrer; F Wyss
Journal:  Respiration       Date:  1970       Impact factor: 3.580

3.  The clinical pharmacology of oral and inhaled salbutamol.

Authors:  S R Walker; M E Evans; A J Richards; J W Paterson
Journal:  Clin Pharmacol Ther       Date:  1972 Nov-Dec       Impact factor: 6.875

4.  Interrelationship of cyclic nucleotides and anaphylactic reactions.

Authors:  C J Coulson; R E Ford; S Marshall; J L Walker; K R Wooldridge; K Bowden; T J Coombs
Journal:  Nature       Date:  1977-02-10       Impact factor: 49.962

5.  A controlled study of cromolyn sodium sponsored by the Drug Committee of the American Academy of Allergy.

Authors:  I L Bernstein; S C Siegel; M L Brandon; E B Brown; R R Evans; A R Feinberg; S Friedlaender; R A Krumholz; R A Hadley; N I Handelman; D Thurston; M Yamate
Journal:  J Allergy Clin Immunol       Date:  1972-10       Impact factor: 10.793

6.  Computer assisted display and analysis of sequential peak flow data.

Authors:  D M Clarkson; E M Lumb; G J McHardy
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

7.  The inhibition of allergen induced bronchospasm in man by oral BRL 10833.

Authors:  R Pauwels; H Lamont; M Van der Straeten
Journal:  Clin Allergy       Date:  1976-09

8.  Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.

Authors:  B A Spicer; J W Ross; H Smith
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

9.  Effect of cromolyn sodium (disodium cromoglycate) on the peripheral eosinophilia of asthmatic children.

Authors:  J G Easton
Journal:  Ann Allergy       Date:  1973-03

Review 10.  Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1974       Impact factor: 9.546
  10 in total
  1 in total

1.  The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35.

Authors:  Amanda E MacKenzie; Gianluigi Caltabiano; Toby C Kent; Laura Jenkins; Jennifer E McCallum; Brian D Hudson; Stuart A Nicklin; Lindsay Fawcett; Rachel Markwick; Steven J Charlton; Graeme Milligan
Journal:  Mol Pharmacol       Date:  2013-10-10       Impact factor: 4.436
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.